Literature DB >> 17609339

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.

Ida Rasmusson1, Michael Uhlin, Katarina Le Blanc, Victor Levitsky.   

Abstract

Mesenchymal stem cells (MSCs), isolated from adult human bone marrow, have immunomodulatory properties. The functional outcomes of MSCs-CTL interactions remain poorly characterized. In this study, we demonstrate that MSCs remain resistant to CTL lysis, even after pulsing with the specific synthetic peptide at high concentrations, in spite of surface expression of the relevant MHC class I allele. MSCs were also much less sensitive to lysis by an allo-specific CTL clone as compared with HLA-matched lymphoblastoid cell lines. MSCs induced CD25 up-regulation, albeit at relatively low levels, and were unable to induce CD3 or CD8 down-regulation at the surface of CTLs. MSCs also failed to induce IFN-gamma and TNF-alpha production by the CTLs. Furthermore, peptide-pulsed MSCs were inefficient in stimulating tyrosine phosphorylation in specific CTLs. Our results demonstrate that MSCs induce only an abortive activation program in fully differentiated, effector CTLs, which does not involve activation of major CTL effector functions. These data may have important implications for the development of therapeutic strategies based on administration of in vitro-expanded MSCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609339     DOI: 10.1189/jlb.0307140

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

Review 1.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

Authors:  Najib El Haddad; Dean Heathcote; Robert Moore; Sunmi Yang; Jamil Azzi; Bechara Mfarrej; Mark Atkinson; Mohamed H Sayegh; Jeng-Shin Lee; Philip G Ashton-Rickardt; Reza Abdi
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

Review 4.  Stem cells in sepsis and acute lung injury.

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

5.  HSCT recipients have specific tolerance to MSC but not to the MSC donor.

Authors:  Mikael Sundin; A John Barrett; Olle Ringdén; Mehmet Uzunel; Helena Lönnies; Asa-Lena Dackland; Birger Christensson; Katarina Le Blanc
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

Review 6.  Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands.

Authors:  Krisztian Nemeth; Balazs Mayer; Eva Mezey
Journal:  J Mol Med (Berl)       Date:  2009-09-13       Impact factor: 4.599

7.  Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis.

Authors:  Olga DelaRosa; Beatriz Sánchez-Correa; Sara Morgado; Cristina Ramírez; Borja del Río; Ramón Menta; Eleuterio Lombardo; Raquel Tarazona; Javier G Casado
Journal:  Stem Cells Dev       Date:  2011-10-18       Impact factor: 3.272

8.  Immunological properties of embryonic and adult stem cells.

Authors:  Francesco Bifari; Luciano Pacelli; Mauro Krampera
Journal:  World J Stem Cells       Date:  2010-06-26       Impact factor: 5.326

9.  Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.

Authors:  Jiang Li; Oleg Andreyev; Man Chen; Michael Marco; Hayato Iwase; Cassandra Long; David Ayares; Zhongyang Shen; David K C Cooper; Mohamed B Ezzelarab
Journal:  Cell Immunol       Date:  2013-08-29       Impact factor: 4.868

Review 10.  The role of recipient T cells in mesenchymal stem cell-based tissue regeneration.

Authors:  Yi Liu; Songlin Wang; Songtao Shi
Journal:  Int J Biochem Cell Biol       Date:  2012-08-09       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.